For the new study, described in the October 23rd issue of Nature Communications, scientists at the Johns Hopkins Kimmel Cancer Center and Dana Farber Cancer Institute in Boston
collected tissue samples containing normal cells,
ovarian cancers, metastases that had spread elsewhere, and small cancers found in the fallopian tubes, which included single cell layers of cancer called «p53 signatures» and serous tubal intraepithelial carcinoma, or STIC lesions.
According to the study authors,
tissue and fluid
collected during a Pap test can detect endometrial and
ovarian cancer in women when subjected to genetic testing.